Citations (85)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Yonghui Yu, Xinping Li, Mengjun Zheng, Linyue Zhou, Jingjie Zhang, Jing Wang & Baoguo Sun. (2023) The potential benefits and mechanisms of protein nutritional intervention on bone health improvement. Critical Reviews in Food Science and Nutrition 0:0, pages 1-15.
Read now
Read now
Emilia Montagna, Paola Zagami, Marianna Masiero, Ketti Mazzocco, Gabriella Pravettoni & Elisabetta Munzone. (2021) Assessing Predictors of Tamoxifen Nonadherence in Patients with Early Breast Cancer. Patient Preference and Adherence 15, pages 2051-2061.
Read now
Read now
Kate Faasse, Anna Perera, Kate Loveys, Andrew Grey & Keith J. Petrie. (2017) Enhancing treatment effectiveness through social modelling: A pilot study. Psychology & Health 32:5, pages 626-637.
Read now
Read now
Akhila Balasubramanian, M Alan Brookhart, Vamshidar Goli & Cathy W Critchlow. (2013) Discontinuation and reinitiation patterns of osteoporosis treatment among commercially insured postmenopausal women. International Journal of General Medicine 6, pages 839-848.
Read now
Read now
Jean-Yves Reginster, Franz Pelousse & Olivier Bruyère. (2013) Safety concerns with the long-term management of osteoporosis. Expert Opinion on Drug Safety 12:4, pages 507-522.
Read now
Read now
Mir Sadat-Ali, Bader Al-Shafie, Abdallah S Al-Omran & Mohammed Q Azam. (2012) Medication burden of Saudi Arabian women receiving antiresorptive therapy. International Journal of Women's Health 4, pages 433-436.
Read now
Read now
E Michael Lewiecki. (2011) Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis. Drug, Healthcare and Patient Safety 3, pages 79-91.
Read now
Read now
Colleen A McHorney & Abhijit S Gadkari. (2010) Individual patients hold different beliefs to prescription medications to which they persist vs nonpersist and persist vs nonfulfill. Patient Preference and Adherence 4, pages 187-195.
Read now
Read now
Véronique Rabenda & Jean-Yves Reginster. (2010) Overcoming problems with adherence to osteoporosis medication. Expert Review of Pharmacoeconomics & Outcomes Research 10:6, pages 677-689.
Read now
Read now
Colleen A. McHorney. (2009) The Adherence Estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Current Medical Research and Opinion 25:1, pages 215-238.
Read now
Read now
Sinéad M Ryan, Giuseppe Mantovani, Xuexuan Wang, David M Haddleton & David J Brayden. (2008) Advances in PEGylation of important biotech molecules: delivery aspects. Expert Opinion on Drug Delivery 5:4, pages 371-383.
Read now
Read now
Oliver Bock & Dieter Felsenberg. (2008) Bisphosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice. Clinical Interventions in Aging 3:2, pages 279-297.
Read now
Read now
Articles from other publishers (73)
Ye Liu, Tarun Arora, Jingyi Zhang, Sandeep K. Sodhi, Fenglong Xie & Jeffrey R. Curtis. (2024) The interruption of romosozumab treatment during COVID lockdown among US post-menopausal women enrolled in Medicare. Bone 178, pages 116954.
Crossref
Crossref
Palak Choksi, Brittany L. Gay, Megan R. Haymart & Maria Papaleontiou. (2023) Physician-Reported Barriers to Osteoporosis Screening: A Nationwide Survey. Endocrine Practice 29:8, pages 606-611.
Crossref
Crossref
Laura Lepage, Didier Poivret & Fabienne Lemétayer. (2023) Relationships between prescribed anti-osteoporotic treatment and necessity-concerns assessment: a psychological network analysis. Current Psychology.
Crossref
Crossref
Hiroyuki Tsuchie, Hidekazu Abe, Norimitsu Masutani & Naohisa Miyakoshi. (2023) Comparison of the Continuation Rate of Twice-Weekly and Weekly Teriparatide Administration in a Rural Area. The Tohoku Journal of Experimental Medicine 260:2, pages 119-126.
Crossref
Crossref
Jingjie Zhang, Qiwei Zhang, Hao Liu, Xinyue Liu, Yonghui Yu, Di Han, Xiaoye He, Ping Zeng & Jing Wang. (2022) Soy-whey dual-protein alleviates osteoporosis of ovariectomized rats via regulating bone fat metabolism through gut-liver-bone axis. Nutrition 103-104, pages 111723.
Crossref
Crossref
Kaiqiang Sun, Fanqi Kong, Feng Lin, Fudong Li, Jingchuan Sun, Changzhen Ren, Bing Zheng & Jiangang Shi. (2022) Vericiguat Modulates Osteoclast Differentiation and Bone Resorption via a Balance between VASP and NF-κB Pathways. Mediators of Inflammation 2022, pages 1-22.
Crossref
Crossref
Sarper Yilmaz, Figen Ünal Çolak, Nihat Müjdat Hökenek & Rohat Ak. (2022) Hesitancy Regarding Medical Advice on COVID-19: An Emergency Department Perspective. Disaster Medicine and Public Health Preparedness, pages 1-11.
Crossref
Crossref
Chong Li, Ke Lu, Qin Shi & Ya-qin Gong. (2022) Predicting the individualized risk of nonadherence to zoledronic acid among osteoporosis patients receiving the first infusion of zoledronic acid: development and validation of new predictive nomograms. Therapeutic Advances in Chronic Disease 13, pages 204062232211142.
Crossref
Crossref
Yasser El Miedany. 2022. New Horizons in Osteoporosis Management. New Horizons in Osteoporosis Management
433
453
.
Yasser El Miedany. 2022. New Horizons in Osteoporosis Management. New Horizons in Osteoporosis Management
387
406
.
Yasser El Miedany. 2022. New Horizons in Osteoporosis Management. New Horizons in Osteoporosis Management
369
386
.
Zoe Paskins, Laurna Bullock, Fay Crawford-Manning, Elizabeth Cottrell, Jane Fleming, Sarah Leyland, John James Edwards, Emma Clark, Simon Thomas, Stephen Robert Chapman, Sarah Ryan, J E Lefroy, Christopher J Gidlow, C Iglesias, Joanne Protheroe, Robert Horne, Terence W O'Neill, Christian Mallen & Clare Jinks. (2021) Improving uptake of Fracture Prevention drug treatments: a protocol for Development of a consultation intervention (iFraP-D). BMJ Open 11:8, pages e048811.
Crossref
Crossref
Tao Huang, Congyun Zhao, Yi Zhao, Yuan Zhou, Lei Wang & Donghua Hang. (2021) RO4929097 regulates RANKL-induced osteoclast formation and LPS-mediated bone resorption. Aging 13:9, pages 12526-12536.
Crossref
Crossref
Deborah T. Gold. 2021. Marcus and Feldman's Osteoporosis. Marcus and Feldman's Osteoporosis
1695
1707
.
G. Koller, V. Goetz, B. Vandermeer, J. Homik, F. A. McAlister, D. Kendler & C. Ye. (2020) Persistence and adherence to parenteral osteoporosis therapies: a systematic review. Osteoporosis International 31:11, pages 2093-2102.
Crossref
Crossref
Z. Paskins, V. D. Torres Roldan, A. W. Hawarden, L. Bullock, S. Meritxell Urtecho, G. F. Torres, L. Morera, N. R. Espinoza Suarez, A. Worrall, S. Blackburn, S. Chapman, C. Jinks & J. P. Brito. (2020) Quality and effectiveness of osteoporosis treatment decision aids: a systematic review and environmental scan. Osteoporosis International 31:10, pages 1837-1851.
Crossref
Crossref
Zhihang Zhou, Xinwei Chen, Xuzhuo Chen, An Qin, Yi Mao, Yichuan Pang, Shiqi Yu & Shanyong Zhang. (2020) PP121 suppresses RANKL-Induced osteoclast formation in vitro and LPS-Induced bone resorption in vivo. Experimental Cell Research 388:2, pages 111857.
Crossref
Crossref
Hiroyuki Tsuchie, Naohisa Miyakoshi, Yuji Kasukawa, Hidekazu Abe, Norimitsu Masutani & Yoichi Shimada. (2019) Factors affecting continuation of weekly teriparatide administration in rural areas. Journal of Bone and Mineral Metabolism 38:2, pages 248-253.
Crossref
Crossref
Jiahong Meng, Wenkan Zhang, Cong Wang, Wei Zhang, Chenhe Zhou, Guangyao Jiang, Jianqiao Hong, Shigui Yan & Weiqi Yan. (2020) Catalpol suppresses osteoclastogenesis and attenuates osteoclast-derived bone resorption by modulating PTEN activity. Biochemical Pharmacology 171, pages 113715.
Crossref
Crossref
Jiahong Meng, Chenhe Zhou, Wenkan Zhang, Wei Wang, Bin He, Bin Hu, Guangyao Jiang, Yangxin Wang, Jianqiao Hong, Sihao Li, Jiamin He, Shigui Yan & Weiqi Yan. (2019) Stachydrine prevents LPS‐induced bone loss by inhibiting osteoclastogenesis via NF‐κB and Akt signalling. Journal of Cellular and Molecular Medicine 23:10, pages 6730-6743.
Crossref
Crossref
Barbara Minkowitz, Leah Nadel, Meghan McDermott, Zachary Cherna, Jennifer Ristic & Stephanie Chiu. (2019) Obtaining Vitamin D Levels in Children With Fractures Improves Supplementation Compliance. Journal of Pediatric Orthopaedics 39:6, pages e436-e440.
Crossref
Crossref
C. T. Yeam, S. Chia, H. C. C. Tan, Y. H. Kwan, W. Fong & J. J. B. Seng. (2018) A systematic review of factors affecting medication adherence among patients with osteoporosis. Osteoporosis International 29:12, pages 2623-2637.
Crossref
Crossref
Stuart L. Silverman & Deborah T. Gold. 2018. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
593
596
.
Fenghu Liu & Shen Wang. (2017) Effect of Tai Chi on bone mineral density in postmenopausal women: A systematic review and meta-analysis of randomized control trials. Journal of the Chinese Medical Association 80:12, pages 790-795.
Crossref
Crossref
Allison KeshishianNatalie BoytsovRussel BurgeKelly KrohnLouise LombardXiang ZhangLin XieOnur Baser. (2017) Examining the Effect of Medication Adherence on Risk of Subsequent Fracture Among Women with a Fragility Fracture in the U.S. Medicare Population. Journal of Managed Care & Specialty Pharmacy 23:11, pages 1178-1190.
Crossref
Crossref
Sylvie F. Hall, Stephanie W. Edmonds, Yiyue Lou, Peter Cram, Douglas W. Roblin, Kenneth G. Saag, Nicole C. Wright, Michael P. Jones & Fredric D. Wolinsky. (2017) Patient-reported reasons for nonadherence to recommended osteoporosis pharmacotherapy. Journal of the American Pharmacists Association 57:4, pages 503-509.
Crossref
Crossref
Joanna E. M. Sale, Cathy Cameron, Stephen Thielke, Lynn Meadows & Kevin Senior. (2017) The theory of planned behaviour explains intentions to use antiresorptive medication after a fragility fracture. Rheumatology International 37:6, pages 875-882.
Crossref
Crossref
Bernard Cortet, Ankita Modi, Jackson Tang, Chun-Po Steve Fan, Shiva Sajjan & Jessica Papadopoulos Weaver. (2016) Association between gastrointestinal events and osteoporosis treatment initiation in women diagnosed with osteoporosis in France: a retrospective analysis. BMC Musculoskeletal Disorders 17:1.
Crossref
Crossref
Julia Thomson. (2016) An overview of osteoporosis. Independent Nurse 2016:17, pages 23-25.
Crossref
Crossref
X. Wu, D. Wei, B. Sun & X. N. Wu. (2016) Poor medication adherence to bisphosphonates and high self-perception of aging in elderly female patients with osteoporosis. Osteoporosis International 27:10, pages 3083-3090.
Crossref
Crossref
Gustavo Duque, Stephen R. Lord, Jenson Mak, Kirtan Ganda, Jacqueline J.T. Close, Peter Ebeling, Alexandra Papaioannou & Charles A. Inderjeeth. (2016) Treatment of Osteoporosis in Australian Residential Aged Care Facilities: Update on Consensus Recommendations for Fracture Prevention. Journal of the American Medical Directors Association 17:9, pages 852-859.
Crossref
Crossref
Inbal Goldshtein, Vanessa Rouach, Naama Shamir-Stein, Jingbo Yu & Gabriel Chodick. (2016) Role of Side Effects, Physician Involvement, and Patient Perception in Non-Adherence with Oral Bisphosphonates. Advances in Therapy 33:8, pages 1374-1384.
Crossref
Crossref
Ethel S. Siris, Chun-Po Steve Fan, Xiaoqin Yang, Shiva Sajjan, Shuvayu S. Sen & Ankita Modi. (2016) Association between gastrointestinal events and compliance with osteoporosis therapy. Bone Reports 4, pages 5-10.
Crossref
Crossref
Gustavo Duque, Pushpa Suriyaarachchi, Piumali Gunawardene & Oddom Demontiero. 2016. Osteoporosis in Older Persons. Osteoporosis in Older Persons
229
241
.
Deborah T. Gold. 2016. The Duration and Safety of Osteoporosis Treatment. The Duration and Safety of Osteoporosis Treatment
239
253
.
Ke Ren, Xin Wei, Lingli Zhang & Dong Wang. 2016. Nanomaterials in Pharmacology. Nanomaterials in Pharmacology
389
412
.
Hideaki Kishimoto & Masayuki Maehara. (2015) Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISA. Archives of Osteoporosis 10:1.
Crossref
Crossref
Ankita Modi, Deborah T. Gold, Xiaoqin Yang, Chun-Po Steve Fan & Shiva G. Sajjan. (2015) Association Between Gastrointestinal Events and Health Care Resource Utilization Among Patients with Osteoporosis: Analysis of a U.S. Managed Care Population. Journal of Managed Care & Specialty Pharmacy 21:9, pages 811-821.
Crossref
Crossref
Taehwan Park, Ronald S. Hadsall, Jon C. Schommer, Cynthia R. Gross, Thomas S. Rector & Mark L. Davison. (2015) Development of an adverse-event coping scale (AECS) using item response theory. Research in Social and Administrative Pharmacy 11:5, pages 651-663.
Crossref
Crossref
Trevor van Mierlo, Rachel Fournier & Michael Ingham. (2015) Targeting Medication Non-Adherence Behavior in Selected Autoimmune Diseases: A Systematic Approach to Digital Health Program Development. PLOS ONE 10:6, pages e0129364.
Crossref
Crossref
C. Klop, P. M. J. Welsing, P. J. M. Elders, J. A. Overbeek, P. C. Souverein, A. M. Burden, H. A. W. van Onzenoort, H. G. M. Leufkens, J. W. J. Bijlsma & F. de Vries. (2015) Long-term persistence with anti-osteoporosis drugs after fracture. Osteoporosis International 26:6, pages 1831-1840.
Crossref
Crossref
S. W. Wade, S. Satram-Hoang & B. S. Stolshek. (2014) Long-term persistence and switching patterns among women using osteoporosis therapies: 24- and 36-month results from POSSIBLE US™. Osteoporosis International 25:9, pages 2279-2290.
Crossref
Crossref
Stephen Gehlbach, Frederick H. Hooven, Allison Wyman, Adolfo Diez-Perez, Jonathan D. Adachi, Xuemei Luo, Andrew G. Bushmakin & Frederick A. Anderson. (2013) Patterns of Anti-Osteoporosis Medication Use among Women at High Risk of Fracture: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). PLoS ONE 8:12, pages e82840.
Crossref
Crossref
Rob Horne, Sarah C. E. Chapman, Rhian Parham, Nick Freemantle, Alastair Forbes & Vanessa Cooper. (2013) Understanding Patients’ Adherence-Related Beliefs about Medicines Prescribed for Long-Term Conditions: A Meta-Analytic Review of the Necessity-Concerns Framework. PLoS ONE 8:12, pages e80633.
Crossref
Crossref
Keri N. Hogan, Jessica L. Milchak, Rachel M. F. Heilmann, Sarah J. Billups & Thomas Delate. (2013) Evaluation of Primary Nonadherence to Oral Bisphosphonate Therapy. Journal of the American Geriatrics Society 61:11, pages 2046-2047.
Crossref
Crossref
K. R. Olsen, C. Hansen & B. Abrahamsen. (2013) Association between refill compliance to oral bisphosphonate treatment, incident fractures, and health care costs—an analysis using national health databases. Osteoporosis International 24:10, pages 2639-2647.
Crossref
Crossref
John T. Schousboe. 2013. Osteoporosis. Osteoporosis
239
262
.
Stephen H. Landy, Ira M. Turner, M. Chris Runken, Mechele Lee, Ellen Sulcs & Christopher F. Bell. (2013) A Cross-Sectional Survey to Assess the Migraineur's Medication Decision-Making Beliefs: Determining When a Migraine Is Triptan-Worthy. Headache: The Journal of Head and Face Pain 53:7, pages 1134-1146.
Crossref
Crossref
John T. Schousboe. (2013) Adherence with Medications Used to Treat Osteoporosis: Behavioral Insights. Current Osteoporosis Reports 11:1, pages 21-29.
Crossref
Crossref
Sarah Jane Besser, Janet E. Anderson & John Weinman. (2012) How do osteoporosis patients perceive their illness and treatment? Implications for clinical practice. Archives of Osteoporosis 7:1-2, pages 115-124.
Crossref
Crossref
E. Barrett-Connor, S. W. Wade, T. P. Do, S. Satram-Hoang, R. Stewart, G. Gao & D. Macarios. (2011) Treatment satisfaction and persistence among postmenopausal women on osteoporosis medications: 12-month results from POSSIBLE US™. Osteoporosis International 23:2, pages 733-741.
Crossref
Crossref
Deborah T. Gold, Rob Horne, Cheryl D. Coon, Mark A. Price, Jeff Borenstein, Sepideh F. Varon, Sacha Satram-Hoang & David Macarios. (2011) Development, Reliability, and Validity of a New Preference and Satisfaction Questionnaire. Value in Health 14:8, pages 1109-1116.
Crossref
Crossref
Sally W. Wade, Sacha Satram-Hoang, Aalok Nadkar, David Macarios & Anna N.A. Tosteson. (2011) Impact of Medication Adherence on Health Care Utilization and Productivity: Self-Reported Data From a Cohort of Postmenopausal Women on Osteoporosis Therapy. Clinical Therapeutics 33:12, pages 2006-2015.
Crossref
Crossref
Abhijit S. Gadkari, Alex Pedan, Neelam Gowda & Colleen A. McHorney. (2011) Survey Nonresponders to a Medication-beliefs Survey Have Worse Adherence and Persistence to Chronic Medications Compared With Survey Responders. Medical Care 49:10, pages 956-961.
Crossref
Crossref
L. Boudou, B. Gerbay, F. Chopin, E. Ollagnier, P. Collet & T. Thomas. (2011) Management of osteoporosis in fracture liaison service associated with long-term adherence to treatment. Osteoporosis International 22:7, pages 2099-2106.
Crossref
Crossref
S. Ojeda-Bruno, A. Naranjo, F. Francisco-Hernández, C. Erausquin, I. Rúa-Figueroa, J. C. Quevedo & C. Rodríguez-Lozano. (2010) Secondary prevention program for osteoporotic fractures and long-term adherence to bisphosphonates. Osteoporosis International 22:6, pages 1821-1828.
Crossref
Crossref
Nesé Yuksel. (2011) Putting Long-Term Adverse Events of Bisphosphonates into Perspective. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada 144:1_suppl, pages S13-S13.e1.
Crossref
Crossref
John T. Schousboe, Mark L. Davison, Bryan Dowd, Kathleen Thiede Call, Paul Johnson & Robert L. Kane. (2011) Predictors of Patients’ Perceived Need for Medication to Prevent Fracture. Medical Care 49:3, pages 273-280.
Crossref
Crossref
S. L. Silverman, J. T. Schousboe & D. T. Gold. (2010) Oral bisphosphonate compliance and persistence: a matter of choice?. Osteoporosis International 22:1, pages 21-26.
Crossref
Crossref
Kathleen M. Mazor, Sarah Velten, Susan E. Andrade & Robert A. Yood. (2010) Older Womenʼs Views about Prescription Osteoporosis Medication. Drugs & Aging 27:12, pages 999-1008.
Crossref
Crossref
J. T. Schousboe, B. E. Dowd, M. L. Davison & R. L. Kane. (2009) Association of medication attitudes with non-persistence and non-compliance with medication to prevent fractures. Osteoporosis International 21:11, pages 1899-1909.
Crossref
Crossref
A. N. A. Tosteson, T. P. Do, S. W. Wade, M. S. Anthony & R. W. Downs. (2010) Persistence and switching patterns among women with varied osteoporosis medication histories: 12-month results from POSSIBLE US™. Osteoporosis International 21:10, pages 1769-1780.
Crossref
Crossref
Gustavo DuqueJacqueline J CloseJulien P JagerPeter R EbelingCharles InderjeethStephen LordAndrew J McLachlanIan R ReidBruce R TroenPhilip N Sambrook. (2010) Treatment for osteoporosis in Australian residential aged care facilities: consensus recommendations for fracture prevention. Medical Journal of Australia 193:3, pages 173-179.
Crossref
Crossref
Suzanne M Cadarette & Andrea M Burden. (2010) Measuring and improving adherence to osteoporosis pharmacotherapy. Current Opinion in Rheumatology 22:4, pages 397-403.
Crossref
Crossref
D. H. Solomon, T. Gleeson, M. Iversen, J. Avorn, M. A. Brookhart, J. Lii, E. Losina, F. May, A. Patrick, W. H. Shrank & J. N. Katz. (2009) A blinded randomized controlled trial of motivational interviewing to improve adherence with osteoporosis medications: design of the OPTIMA trial. Osteoporosis International 21:1, pages 137-144.
Crossref
Crossref
José Sanfelix-Genovés, Vicente F. Gil-Guillén, Domingo Orozco-Beltran, Vicente Giner-Ruiz, Salvador Pertusa-Martínez, Begoña Reig-Moya & Concepción Carratalá. (2009) Determinant Factors of Osteoporosis Patientsʼ Reported Therapeutic Adherence to Calcium and/or Vitamin D Supplements. Drugs & Aging 26:10, pages 861-869.
Crossref
Crossref
THE BonAdASIA STUDY GROUP. (2009) Impact of bone marker feedback on adherence to once monthly ibandronate for osteoporosis among Asian postmenopausal women. International Journal of Rheumatic Diseases 12:3, pages 216-224.
Crossref
Crossref
Patrick O. Monahan, Kathleen A. Lane, Risa P. Hayes, Colleen A. McHorney & David G. Marrero. (2009) Reliability and validity of an instrument for assessing patients’ perceptions about medications for diabetes: the PAM-D. Quality of Life Research 18:7, pages 941-952.
Crossref
Crossref
Amy H Warriner & Jeffrey R Curtis. (2009) Adherence to osteoporosis treatments: room for improvement. Current Opinion in Rheumatology 21:4, pages 356-362.
Crossref
Crossref
R. Civitelli, R. Armamento-Villareal & N. Napoli. (2009) Bone turnover markers: understanding their value in clinical trials and clinical practice. Osteoporosis International 20:6, pages 843-851.
Crossref
Crossref
Sinéad M. Ryan, Xuexuan Wang, Guiseppe Mantovani, Claire T. Sayers, David M. Haddleton & David J. Brayden. (2009) Conjugation of salmon calcitonin to a combed-shaped end functionalized poly(poly(ethylene glycol) methyl ether methacrylate) yields a bioactive stable conjugate. Journal of Controlled Release 135:1, pages 51-59.
Crossref
Crossref
Julie Blouin, Alice Dragomir, Yola Moride, Louis-Georges Ste-Marie, Julio Cesar Fernandes & Sylvie Perreault. (2008) Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women. British Journal of Clinical Pharmacology 66:1, pages 117-127.
Crossref
Crossref
. (2008) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 17:7.
Crossref
Crossref